Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiangiogenic Treatment of Advanced or Metastatic Hepatocellular Cancer (HCC)
2007-005422-76Phase 2Completed
- Sponsor
- PD Dr. Gerhard Treiber
- Start
- Jan 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of everolimus and bevacizumab in hepatocellular carcinoma (HCC), sponsored by PD Dr. Gerhard Treiber. Primary endpoint: Time-to-Progression. Started Jan 2009; status: completed.
02
Drugs
everolimusbevacizumab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2007-005422-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005422-76.